84 related articles for article (PubMed ID: 8844688)
21. Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny.
Wilder PJ; Kelly D; Brigman K; Peterson CL; Nowling T; Gao QS; McComb RD; Capecchi MR; Rizzino A
Dev Biol; 1997 Dec; 192(2):614-29. PubMed ID: 9441693
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the transforming growth factor-beta 2 gene promoter in embryonal carcinoma cells and their differentiated cells: differential utilization of transcription factors.
Kelly D; Scholtz B; Orten DJ; Hinrichs SH; Rizzino A
Mol Reprod Dev; 1995 Feb; 40(2):135-45. PubMed ID: 7766406
[TBL] [Abstract][Full Text] [Related]
23. The FGF-4 promoter is required for transformation and is active in both embryonal and somatic cells.
Lucas JM; Bryans M; Lo K; Wilkie NM; Freshney M; Thornton D; Lang JC
Oncol Res; 1994; 6(3):139-49. PubMed ID: 7994085
[TBL] [Abstract][Full Text] [Related]
24. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
Bernadt CT; Rizzino A
Mol Reprod Dev; 2003 Aug; 65(4):353-65. PubMed ID: 12840808
[TBL] [Abstract][Full Text] [Related]
25. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
Miller K; Rizzino A
Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204
[TBL] [Abstract][Full Text] [Related]
26. Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter.
Yang HM; Do HJ; Oh JH; Kim JH; Choi SY; Cha KY; Chung HM; Kim JH
J Cell Biochem; 2005 Nov; 96(4):821-30. PubMed ID: 16149048
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of the murine Elf3 gene in embryonal carcinoma cells and their differentiated counterparts: requirement for a novel upstream regulatory region.
Hou J; Wilder PJ; Bernadt CT; Boer B; Neve RM; Rizzino A
Gene; 2004 Sep; 340(1):123-31. PubMed ID: 15556300
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Sp1 binding sequences in basal transcription of the rat fibroblast growth factor-2 gene in neonatal cardiomyocytes.
Tang W; Pan Q; Sun F; Ma J; Tang S; Le K; Wan Y; Chen Q; Liu P
Life Sci; 2009 Mar; 84(13-14):421-7. PubMed ID: 19302822
[TBL] [Abstract][Full Text] [Related]
29. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.
Dailey L; Yuan H; Basilico C
Mol Cell Biol; 1994 Dec; 14(12):7758-69. PubMed ID: 7969117
[TBL] [Abstract][Full Text] [Related]
30. GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis.
Fandos C; Sánchez-Feutrie M; Santalucía T; Viñals F; Cadefau J; Gumà A; Cussó R; Kaliman P; Canicio J; Palacín M; Zorzano A
J Mol Biol; 1999 Nov; 294(1):103-19. PubMed ID: 10556032
[TBL] [Abstract][Full Text] [Related]
31. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.
Barth N; Langmann T; Schölmerich J; Schmitz G; Schäffler A
Diabetologia; 2002 Oct; 45(10):1425-33. PubMed ID: 12378384
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL
Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367
[TBL] [Abstract][Full Text] [Related]
33. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
Yuan H; Corbi N; Basilico C; Dailey L
Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of the murine k-FGF gene in embryonic cell lines.
Ma YG; Rosfjord E; Huebert C; Wilder P; Tiesman J; Kelly D; Rizzino A
Dev Biol; 1992 Nov; 154(1):45-54. PubMed ID: 1426633
[TBL] [Abstract][Full Text] [Related]
35. Developmentally regulated expression of fibroblast growth factor receptor genes and splice variants by murine embryonic stem and embryonal carcinoma cells.
McDonald FJ; Heath JK
Dev Genet; 1994; 15(2):148-54. PubMed ID: 8205724
[TBL] [Abstract][Full Text] [Related]
36. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.
Ambrosetti DC; Basilico C; Dailey L
Mol Cell Biol; 1997 Nov; 17(11):6321-9. PubMed ID: 9343393
[TBL] [Abstract][Full Text] [Related]
37. Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.
Curatola AM; Basilico C
Mol Cell Biol; 1990 Jun; 10(6):2475-84. PubMed ID: 2188089
[TBL] [Abstract][Full Text] [Related]
38. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene.
Nowling T; Bernadt C; Johnson L; Desler M; Rizzino A
J Biol Chem; 2003 Apr; 278(16):13696-705. PubMed ID: 12488456
[TBL] [Abstract][Full Text] [Related]
39. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
Kryszke MH; Piette J; Yaniv M
Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
[TBL] [Abstract][Full Text] [Related]
40. NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.
Bernadt CT; Nowling T; Wiebe MS; Rizzino A
Gene Expr; 2005; 12(3):193-212. PubMed ID: 16128003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
